论文部分内容阅读
目的 总结Ⅱ期乳腺癌采用仿根治术治疗的远期效果。方法 346例Ⅱ期乳腺癌 ,采用仿根治术(MRM组 ) 2 95例 ,其中仿根治术Ⅰ式 (MRMⅠ组 ) 174例 ,仿根治术Ⅱ式 (MRMⅡ组 ) 12 1例 ,标准根治术 (Halsted手术 ,HRM组 ) 5 1例。治疗后随访 8年以上。比较各种手术术式与病人生存率的关系。结果 MRM和HRM两组病人 8年总生存率分别为 73 9%和 70 6 % ,差异无显著意义。在淋巴结阳性病人中 ,MRMⅡ组生存率高于MRMⅠ组 (分别为 73 %和 5 1% ,P <0 0 1)。结论 Ⅱ期乳腺癌采用仿根治术治疗 ,远期效果同Halsted根治术。对腋淋巴结有转移的宜采用仿根治术Ⅱ式
Objective To summarize the long-term results of radical mastectomy for stage II breast cancer. Methods A total of 346 patients with stage Ⅱ breast cancer were enrolled in this study. A total of 2 95 MRM patients were treated with radical mastectomy (MRMⅠ), including 174 cases with MRM Ⅰ and 121 cases with MRM Ⅱ (radical MRM Ⅱ) Halsted surgery, HRM group) 51 cases. After treatment for more than 8 years. Comparison of various surgical procedures and the relationship between patient survival. Results The overall 8-year survival rates of MRM and HRM patients were 73 9% and 70 6% respectively, with no significant difference. Among patients with positive lymph nodes, the survival rate of MRMⅡgroup was higher than that of MRMⅠgroup (73% and 51% respectively, P <0.01). Conclusions Stage II breast cancer is treated with mimicking radical mastectomy. The long-term effect is the same as that of Halsted radical mastectomy. Transplantation of axillary lymph nodes should adopt the imitation of radical surgery type Ⅱ